Skip to content

LVIS 213025-LVIS-D-PMARecalls & reported problems

Microvention, Inc. · Stent · Class 3 · Implant

All models of LVIS (17)

Data updated Oct 18, 2026 from official FDA records · Editorial policy

Adverse event reports
3
Deaths reported
0
Injuries reported
3
Recalls naming it
0

Summary

The FDA's MAUDE database contains 3 adverse event reports that list this exact device (DI 00842429100950), received between Oct 12, 2021 and Sep 11, 2025 — classified as 3 injuries.

The most frequently reported specific device problem is “Activation Failure” (1 report).

Reports come from manufacturers, hospitals and patients and are not verified by the FDA. A report does not prove the device caused the event, and counts can't be used to compare devices or estimate failure rates. What reports can and can't tell you · How this data works · Data updated Oct 18, 2026.

Reports received per month

Nov 2023: 0 reportsDec 2023: 0 reportsJan 2024: 0 reportsFeb 2024: 0 reportsMar 2024: 0 reportsApr 2024: 0 reportsMay 2024: 0 reportsJun 2024: 0 reportsJul 2024: 0 reportsAug 2024: 0 reportsSep 2024: 0 reportsOct 2024: 0 reportsNov 2024: 0 reportsDec 2024: 0 reportsJan 2025: 0 reportsFeb 2025: 0 reportsMar 2025: 0 reportsApr 2025: 0 reportsMay 2025: 0 reportsJun 2025: 0 reportsJul 2025: 0 reportsAug 2025: 0 reportsSep 2025: 2 reportsOct 2025: 0 reportsNov 2025: 0 reportsDec 2025: 0 reportsJan 2026: 0 reportsFeb 2026: 0 reportsMar 2026: 0 reportsApr 2026: 0 reportsMay 2026: 0 reportsJun 2026: 0 reportsJul 2026: 0 reportsAug 2026: 0 reportsSep 2026: 0 reportsOct 2026: 0 reports2024202520262
Last 36 months. The most recent month may be incomplete.

Most reported problems

Device problems

  • Adverse Event Without Identified Device or Use Problem2
  • Activation Failure1

Patient problems

  • Aneurysm1
  • Cerebral Edema1
  • Extravasation1
  • Hemorrhage/Blood Loss/Bleeding1
  • Intracranial Hemorrhage1
  • Ischemia1
  • Obstruction/Occlusion1
  • Rupture1

Recent adverse event reports

The 3 most recent of 3 reports, in the reporter's own words as published by the FDA.

  • InjurySep 11, 2025Adverse Event Without Identified Device or Use Problem; Adverse Event Without Identified Device or Use Problem

    AS REPORTED THROUGH THE LVIS PAS STUDY: AE NAME: P1 OCCLUSION. EVENT ONSET DATE: 8-APR-2022. EVENT DESCRIPTION: POD 1 PATIENT¿S STENT ASSISTED COIL EMBOLIZATION WAS COMPLICATED BY STENT OCCLUSION. UNDERWENT MECHANICAL THROMBECTOMY ON (B)(6) 2022. DECREASED LEVEL OF CONSCIOUSNESS PRIOR TO PROCEDURE, SYMPTOMS RESOLVED (MINUS RLE WEAKNESS-WHICH WAS POA) AFTER PROCEDURE. RELATEDNESS: STUDY PROCEDURE-RELATED, STUDY DEVICE-RELATED. DATE REPORTED TO THE SPONSOR: 18-AUG-2025. DATE OF INDEX PROCEDURE: ON (B)(6) 2022. IS THE EVENT A SERIOUS ADVERSE EVENT? YES. OUTCOME: RESOLVED WITHOUT SEQUELAE. DOES THE EVENT MEET CRITERIA FOR AN UNANTICIPATED ADVERSE DEVICE EFFECT? NO. ADDITIONAL INFORMATION: EVENT SUMMARY FOR AE#2 ISCHEMIC STROKE: NEURO EVALUATION ON (B)(6) 2023 (POD 298) SHOWED CHRONIC RIGHT LOWER EXTREMITY WEAKNESS BUT NEW FACE AND ARM WEAKNESS. PATIENT WAS OUTSIDE WINDOW FOR TPA AND HAS NO MOTOR DEFICIT SO WOULD NOT REALLY BE THROMBECTOMY CANDIDATE AS LARGE VESSEL OCCLUSION WAS NOT SUSPECTED. BRAIN MRI REVEALED A TINY ACUTE SMALL VESSEL ISCHEMIA IN THE SUBCORTICAL WHITE MATTER OF THE POSTERIOR LEFT PARIETAL LOBE AND LEFT OCCIPITAL LOBE. MRA SHOWED PUNCTATE AREAS OF ACUTE SMALL VESSEL I

    Patient problems: Obstruction/Occlusion; Stroke/CVA; Thrombosis/Thrombus

    MAUDE report 23033994 ↗
  • InjurySep 5, 2025Adverse Event Without Identified Device or Use Problem; Adverse Event Without Identified Device or Use Problem

    IT WAS REPORTED THROUGH THE LVIS PAS CLINICAL STUDY. AN AE HAS BEEN REPORTED FOR SUBJECT (B)(6) AT SITE USA-19. AE NAME : INTRAOPERATIVE ANEURYSM RUPTURE, EVENT ONSET DATE : JUN 26, 2019, EVENT DESCRIPTION : INTRAOPERATIVE ANEURYSM RUPTURE, SPECIFY THE EVENT LOCATION: IPSILATERAL TO TARGET LESION, WAS THE EVENT A STROKE?: YES, RELATEDNESS : STUDY DEVICE-RELATED , SPECIFY CLINICAL OUTCOME" SUBARACHNOID HEMORRHAGE, DATE REPORTED TO THE SPONSOR : (B)(6) 2025, DATE OF INDEX PROCEDURE : (B)(6) 2018 , IS THE EVENT A SERIOUS ADVERSE EVENT?: YES , OUTCOME: RESOLVED WITH SEQUELAE . ADDITIONAL INFORMATION RECEIVED STATED THAT THE CEC ADJUDICATED AS STUDY DEVICE-RELATED, STUDY PROCEDURE-RELATED. BASED ON CEC REVIEW IT WAS MINOR INTRAOPERATIVE RUPTURE WITH MINOR CONSEQUENCE. DUE TO THE ADJUDICATION THE SITE REPORTED AS DISEASE-RELATED. CEC ADJUDICATED AS STUDY DEVICE-RELATED, STUDY PROCEDURE-RELATED. CT OBTAINED (B)(6) 2019 (POD 1) SHOWED SMALL AMOUNT OF SUBARACHNOID HEMORRHAGE AND MILD CEREBRAL EDEMA. TREATED WITH MANNITOL, DECADRON AND OXYTOCIN. HEADACHE, NAUSEA, VOMITING IMPROVED ON (B)(6) 2019. TOLERATING LOW DOSE NIMODIPINE. SUBJECT HAD SOME PERSONAL ISSUES WITH CAR ACCIDENT AND HOME BROK

    Patient problems: Aneurysm; Intracranial Hemorrhage

    MAUDE report 22986594 ↗
  • InjuryOct 12, 2021Activation Failure; Activation Failure

    IT WAS REPORTED THAT AN LVIS D STENT WAS IMPLANTED TO TREAT A RUPTURED BASILAR TIP ANEURYSM. AFTER DEPLOYING THE STENT, THE BASILAR TIP ANEURYSM WAS COILED SUCCESSFULLY. AN ANGIOGRAM WAS THEN PERFORMED, WHICH SHOWED THE RIGHT END OF LVIS STENT IN THE PCA NOT FULLY DEPLOYED AND THAT THE RIGHT PCA WAS OCCLUDED. A SCEPTER XC WAS ADVANCED UNDER FLUOROSCOPY AND INFLATED. AN ANGIOGRAM PERFORMED POST INFLATION SHOWED A PCA RUPTURE WITH EXTRAVASATION. THE RIGHT PCA WAS COILED TO ADDRESS THE HEMORRHAGE. AFTERWARDS, AN ANGIOGRAM SHOWED LIMITED FLOW IN THE BASILAR ARTERY AND BRAIN EDEMA. THE PATIENT IS IN CRITICAL CONDITION AND INTUBATED. THE DEVICE ASSOCIATED WITH THIS EVENT WAS USED DURING THE SAME PROCEDURE REFERENCED IN MFR. REPORT # 2032493-2021-00414.

    Patient problems: Cerebral Edema; Extravasation; Hemorrhage/Blood Loss/Bleeding; Ischemia; Rupture

    MAUDE report 12616271 ↗

Other Intracranial Coil-Assist Stent devices

All Intracranial Coil-Assist Stent devices →

Sources and updates

How reports and recalls are matched · Editorial policy · Report an error on this page